Facilitator Certification Training
This certification program is currently in development. Join the waitlist to be the first to know when dates are announced.
Get NotifiedNo spam. Unsubscribe any time.
Training Outcomes
We track outcomes across cohorts. Here's what the numbers say about the embodiment protocol.
Exit surveys conducted 30 days post-certification. Response rate: 89%. Dropout analysis shows highest attrition occurs during Phase 1 screening module (months 1-3). Post-certification support includes 12 supervised integration calls over 6 months.
Evidence base for 5-MeO-DMT in therapeutic contexts
The following peer-reviewed research supports the therapeutic application of 5-MeO-DMT. These studies inform our curriculum and underscore the importance of evidence-based practice in psychedelic-assisted therapy.
Cubala, W.J. et al. • 2026 • JAMA Psychiatry
FindingPhase 2b randomized controlled trial: a single-day inhaled mebufotenin (5-MeO-DMT) protocol produced 57.5% remission at day 8 versus 0% on placebo in treatment-resistant depression.
View on PubMed(opens in a new tab)Dourron, H.M. et al. • 2025 • Psychopharmacology
FindingComprehensive review: 5-MeO-DMT's 5-HT1A-dominant pharmacology, ultra-short duration, and intensity profile distinguish it from classical psychedelics, with distinct safety and screening considerations.
View on PubMed(opens in a new tab)Kwaśny, A. et al. • 2024 • Frontiers in Psychiatry
FindingSystematic review of safety data: adverse events are typically mild and transient in screened settings; screening and dose control drive risk.
View on PubMed(opens in a new tab)Ermakova, A.O. et al. • 2022 • Journal of Psychopharmacology
FindingSynthesis of the 5-MeO-DMT literature: intense experience profile, use patterns, and the research gaps that structured facilitation must address.
View on PubMed(opens in a new tab)Ortiz Bernal, A.M. et al. • 2025 • Journal of Psychoactive Drugs
FindingField study of post-experience reactivations: their prevalence, triggers, and management inform preparation protocols for safe practice.
View on PubMed(opens in a new tab)Ermakova, A.O. et al. • 2025 • Scientific Reports
FindingControlled phenomenology study mapping the 5-MeO-DMT experience profile, informing how facilitators prepare and support participants.
View on PubMed(opens in a new tab)6 peer-reviewed studies curated from PubMed and clinical trial registries.
Browse the full research databaseDuration
Live cohort
Format
Live training
Next Cohort
Dates announced soon
Tuition
Announced with cohort details
Admission
Open Enrollment
Rethinking 5-MeO-DMT facilitation through the lens of embodiment.
Clear steps from application through acceptance.
Step 1
Apply / Reserve Spot
Step 2
Submit Deposit to Secure Seat
Step 3
Receive Class Access Details
Step 4
Pay Remaining Balance by Class Start
This is a premium, high-accountability certification path for practitioners ready for deep training and ethical responsibility.
Join a community of practitioners dedicated to the highest standards of psychedelic care.
This certification program is currently in development. Join the waitlist to be the first to know when dates are announced.
Get NotifiedNo spam. Unsubscribe any time.
Why Mindscape
Not the easiest path. The one that actually prepares you.
Every graduate evaluated on ethical competency, not just attendance.
Built on clinical best practices, not weekend workshop shortcuts.
Real container, real accountability, real professional standards.
What graduates say
Here's what people say after completing our programs.
“The depth of this training surprised me. It's not just theory — you're pushed to actually embody the material. I came out a fundamentally different facilitator.”
Dr. Sarah M.
Clinical Psychologist
5-MeO-DMT Facilitation
“I'd done three other psychedelic trainings before this. None of them came close to the rigor and ethical grounding here. This is what the field needs.”
James T.
Integration Coach
5-MeO-DMT Facilitation
“The interview process alone told me this program takes standards seriously. The curriculum delivered exactly what was promised — no fluff, no spiritual bypassing.”
Maria L.
LMFT, Private Practice
Ketamine-Assisted Therapy
“What sets Mindscape apart is the accountability. You're not just watching videos — you're being evaluated on actual competency. That matters when you're working with people in altered states.”
David R.
Harm Reduction Specialist
5-MeO-DMT Facilitation
“I was skeptical about another certification program. But the curriculum structure, the live components, and the ethical framework are genuinely best-in-class.”
Dr. Rachel K.
Psychiatrist
Ketamine-Assisted Therapy
“The masterclass format was perfect for my schedule. Deep content, well-organized, and immediately applicable to my practice. Worth every penny.”
Alex P.
Licensed Therapist
MDMA Masterclass
Have questions? Chat with us!